Glaxosmithkline PLC, 10% Owner at GENOCEA BIOSCIENCES, INC. (GNCA), bought 1,260,504 shares at $2.25 ($2.8M) on 2020-07-24, disclosed to the SEC on 2020-07-30.
Open-market purchase of $2.8M GNCA by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| Filing → |
| DBTX | BUY | 2021-02-19 | $2.7M | — | Filing → |
| BCYC | SELL | 2020-09-18 | $151K | — | Filing → |
| PAND | BUY | 2020-07-22 | $6.5M | — | Filing → |